Innova was created by the Memphis Bioworks Foundation to make investments in early- stage companies with high growth potential. MemphisED capitalized the Innova I fund and supports on-going administrative costs. The State of Tennessee selected Innova for the TNInvestco program, which provided $14.3 million of additional investment capital for the Innova II fund.
MB Venture Partners is a venture capital firm specializing in investments in all stages of development. MB Ventures invests in life sciences sectors including biotechnology and medical device companies with a focus on: product solutions for musculoskeletal diseases, products to alleviate human suffering, and molecular therapeutics. It seeks to invest in opportunities across the United States for musculoskeletal related investments and Southeast and Midwest regions for investments in biotechnology, medical devices companies, and non-musculoskeletal investments. MB Venture Partners was founded in 2001 and is based in Memphis, Tennessee.
The Zeroto510 program
The majority of medical devices get cleared for commercial deployment through the FDA’s 510(k) approval process, which is the fastest and most economical route to market for a new medical device. ZeroTo510 has developed a unique program that enables entrepreneurs with ideas for innovative medical devices to take advantage of the fast path to market. ZeroTo510 is a first-of-its-kind cohort-based medical device accelerator. Hosted in Memphis, Tennessee, the program leverages key regional strengths in bio-medical research and medical device manufacturing to create a unique program.